« Previous
Next »
European Journal of Vascular & Endovascular Surgery
Volume 34, Issue 3
, Pages
314-321
, September 2007
Medical Therapy for Intermittent Claudication
-
Effect of cilostazol 100
mg bid (○, n
=
227) on maximum (treadmill) walking distance, relative to baseline, compared with placebo (■, n
=
239) and pentoxifylline 400
mg tds (▴, n
=
232). *p
<
0.05 vs placeboEffect of cilostazol 100
mg bid (○, n
=
227) on maximum (treadmill) walking distance, relative to baseline, compared with placebo (■, n
=
239) and pentoxifylline 400
mg tds (▴, n
=
232). *p
<
0.05 vs placebo; ‡ p
<
0.05 vs pentoxifylline. Adapted from Dawson et al.[20] -
A summary of the efficacy data from the 4 published placebo-controlled trials of cilostazol for changes in maximum treadmill walking distance (and 95% confidence intervals). Adapted from reference 22.A summary of the efficacy data from the 4 published placebo-controlled trials of cilostazol for changes in maximum treadmill walking distance (and 95% confidence intervals). Adapted from reference 22.
-
Angiogenesis involves endothelial cell activation, migration and proliferation, followed by expansion and remodelling of extracellular matrix and smooth muscle cell recruitment (arteriogenesis) to forAngiogenesis involves endothelial cell activation, migration and proliferation, followed by expansion and remodelling of extracellular matrix and smooth muscle cell recruitment (arteriogenesis) to form luminal structures capable of maintaining systemic blood pressure. The regulation of angiogenesis is complex, but involves a balance between pro- and anti-angiogenic growth factors.
PII: S1078-5884(07)00266-3
doi: 10.1016/j.ejvs.2007.04.001
© 2007 European Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
European Journal of Vascular & Endovascular Surgery
Volume 34, Issue 3
, Pages
314-321
, September 2007
